Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?

Pro-Dex, Inc. (NASDAQ:PDEX)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $37.70 and traded as high as $47.60. Pro-Dex shares last traded at $45.67, with a volume of 58,396 shares trading hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Pro-Dex in a research report on Monday, December 29th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, Pro-Dex has an average rating of “Moderate Buy” and an average target price of $56.00.

Pro-Dex Trading Up 3.5%

The company has a quick ratio of 2.25, a current ratio of 4.03 and a debt-to-equity ratio of 0.19. The business’s fifty day moving average is $41.67 and its 200 day moving average is $37.78. The stock has a market cap of $155.56 million, a PE ratio of 14.25 and a beta of -0.04.

Pro-Dex (NASDAQ:PDEX) last issued its earnings results on Thursday, January 29th. The medical instruments supplier reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.07. The company had revenue of $18.66 million during the quarter, compared to analysts’ expectations of $17.30 million. Pro-Dex had a net margin of 15.73% and a return on equity of 22.53%. As a group, analysts predict that Pro-Dex, Inc. will post 2 earnings per share for the current year.

Hedge Funds Weigh In On Pro-Dex

Several hedge funds and other institutional investors have recently bought and sold shares of the company. D.A. Davidson & CO. grew its holdings in Pro-Dex by 152.3% in the third quarter. D.A. Davidson & CO. now owns 26,073 shares of the medical instruments supplier’s stock valued at $883,000 after purchasing an additional 15,738 shares during the last quarter. CreativeOne Wealth LLC acquired a new position in Pro-Dex during the second quarter worth about $297,000. Hillsdale Investment Management Inc. purchased a new stake in shares of Pro-Dex in the second quarter valued at about $157,000. First Trust Advisors LP acquired a new stake in shares of Pro-Dex in the fourth quarter valued at approximately $222,000. Finally, Quadrature Capital Ltd acquired a new stake in shares of Pro-Dex in the fourth quarter valued at approximately $220,000. 15.28% of the stock is owned by institutional investors and hedge funds.

Pro-Dex Company Profile

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.